Faculty

Institution

Unit

Venue

Hojong Yoon

Assistant Professor

The University of Texas MD Anderson Cancer Center

Affiliations

James P. Allison Institute

Hojong Yoon is currently serving as a James P. Allison Institute Assistant Professor at The University of Texas Md Anderson Cancer Center.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Hojong Yoon

The University of Texas MD Anderson Cancer Center

Assistant Professor

You can click a keyword to filter the displayed items

drug discovery pharmacology medicine medicinal chemistry cellular therapy medicinal research hematology cancer research molecular medicine enzyme inhibition future medicinal chemistry cancer genetics pathway analysis hematological malignancies neurology biochemistry oncology biosynthesis bioorganic chemistry laboratory medicine pharmacotherapy marine drug organic chemistry frontier natural product research pharmacognosy organic process research natural product communication pharmacological research pharmaceutics brain tumor research cellular physiology therapeutic efficacy novel therapies receptor tyrosine kinases pharmaceutical chemistry cancer biology signaling pathways nras mutations acute leukemias novel therapeutic targets focal adhesion kinase dual inhibitors glioma mutant n-ras acute leukemia cells biophysical chemistry synthetic biology biochemical sciences computational biology bioenergetics cell biology molecular and cellular biology protein science microbiology biomolecular structure protein engineering proteomics molecular informatics biomolecular engineering biotechnology advance cellular biochemistry molecular biophysics biological engineering protein design biology bioanalysis process biochemistry biochemical engineering biological chemistry structural biology proteome research protein structure redox biology structural molecular biology microbial cell factory biotechnology enzymes chemical biology cell and molecular biology biophysics protein folding applied microbiology molecular metabolism nucleic acids molecular biology molecular science systems biology peptides biological macromolecules glycobiology biomolecules metabolic engineering

Notable Scholarly Works

Notable Federal Grants

Collaborators

Identification of Thieno[3,2- D ]Pyrimidine Derivatives as Dual Inhibitors of Focal Adhesion Kinase and Fms-Like Tyrosine Kinase 3. Journal of Medicinal Chemistry (2021)

Hanna ChoInjae ShinHojong YoonEunhye JeonJiwon LeeYounghoon KimSeongShick RyuChiman SongNam Hoon KwonYoungji MoonSunghoon KimNam Doo KimHwan Geun ChoiTaebo Sim

medicinal chemistrymedicineenzyme inhibitionpharmacologypharmaceutical chemistryreceptor tyrosine kinasesdrug discoverydual inhibitorsfocal adhesion kinase

In Situ Imaging of Quantum Dot-Azd4547 Conjugates for Tracking the Dynamic Behavior of Fibroblast Growth Factor Receptor 3. International Journal of Nanomedicine (2017)

Identification of a Novel 5-Amino-3-(5-Cyclopropylisoxazol-3-Yl)-1-Isopropyl-1H-Pyrazole-4-Carboxamide as a Specific Ret Kinase Inhibitor. European Journal of Medicinal Chemistry (2016)

イソオキサゾール成分を含有するピラゾロ[3,4‐D]ピリミジン‐4‐アミノ誘導体はretゲートキーパー突然変異の選択的で強力な阻害剤である. Journal of Medicinal Chemistry (2016)

mechanicsengineering scienceboundary value problems

A Pyrazolo[3,4- D ]Pyrimidin-4-Amine Derivative Containing an Isoxazole Moiety is a Selective and Potent Inhibitor of Ret Gatekeeper Mutants. Journal of Medicinal Chemistry (2015)

Double Blockade of Glioma Cell Proliferation and Migration by Temozolomide Conjugated With Nppb, a Chloride Channel Blocker. ACS Chemical Neuroscience (2015)

medicinal chemistrypharmacologycellular physiologyfuture medicinal chemistryradiation oncologybrain tumor researchtherapeutic targetsmolecular pharmacologycellular therapydrug discoveryneuro-oncologymedicinal researchcell biologygliomadrug deliverypharmacological researchpharmaceutics

Identification of Novel Therapeutic Targets in Acute Leukemias With Nras Mutations Using a Pharmacologic Approach. Blood (2015)

Atsushi NonamiMartin SattlerEllen WeisbergQingsong LiuJianming ZhangMatthew P. PatricelliAmanda L. ChristieAmy M. SaurNancy E. KohlAndrew L. KungHojong YoonTaebo SimNathanael S. GrayJames D. Griffin

hematological malignanciescancer geneticsnovel therapiestherapeutic efficacypathway analysisneurologymedicinehematologyacute leukemiasnovel therapeutic targetslaboratory medicinecancer researchenzyme inhibitionpharmacologypharmacotherapydrug discoveryoncologynras mutationsmedicinal researchcellular therapymolecular medicine

Asymmetric Synthesis of (+)-Lentiginosine Using a Chiral Aziridine Based Approach. Tetrahedron Asymmetry (2014)

medicinal chemistrybiosynthesisorganic chemistrybioorganic chemistryfuture medicinal chemistrymarine drugorganic synthesisbiomolecular engineeringdrug discoverynatural product communicationchemistrybiochemistryorganic chemistry frontiernatural product researchchemical synthesisorganic process researchpharmacognosy

Cheminform Abstract: Asymmetric Synthesis of (+)‐Lentiginosine Using a Chiral Aziridine Based Approach.. ChemInform (2014)

Cheminform Abstract: Stereoselective Synthesis of (+)‐Polyoxamic Acid Starting With a Chiral Aziridine.. ChemInform (2014)

1
2
10 / page

Hojong Yoon

Assistant Professor

The University of Texas MD Anderson Cancer Center

Affiliations

James P. Allison Institute

Hojong Yoon is currently serving as a James P. Allison Institute Assistant Professor at The University of Texas Md Anderson Cancer Center.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Hojong Yoon

The University of Texas MD Anderson Cancer Center

Assistant Professor

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

Identification of Thieno[3,2- D ]Pyrimidine Derivatives as Dual Inhibitors of Focal Adhesion Kinase and Fms-Like Tyrosine Kinase 3. Journal of Medicinal Chemistry (2021)

Hanna ChoInjae ShinHojong YoonEunhye JeonJiwon LeeYounghoon KimSeongShick RyuChiman SongNam Hoon KwonYoungji MoonSunghoon KimNam Doo KimHwan Geun ChoiTaebo Sim

medicinal chemistrymedicineenzyme inhibitionpharmacologypharmaceutical chemistryreceptor tyrosine kinasesdrug discoverydual inhibitorsfocal adhesion kinase

In Situ Imaging of Quantum Dot-Azd4547 Conjugates for Tracking the Dynamic Behavior of Fibroblast Growth Factor Receptor 3. International Journal of Nanomedicine (2017)

Identification of a Novel 5-Amino-3-(5-Cyclopropylisoxazol-3-Yl)-1-Isopropyl-1H-Pyrazole-4-Carboxamide as a Specific Ret Kinase Inhibitor. European Journal of Medicinal Chemistry (2016)

mechanicsengineering scienceboundary value problems

A Pyrazolo[3,4- D ]Pyrimidin-4-Amine Derivative Containing an Isoxazole Moiety is a Selective and Potent Inhibitor of Ret Gatekeeper Mutants. Journal of Medicinal Chemistry (2015)

Double Blockade of Glioma Cell Proliferation and Migration by Temozolomide Conjugated With Nppb, a Chloride Channel Blocker. ACS Chemical Neuroscience (2015)

Identification of Novel Therapeutic Targets in Acute Leukemias With Nras Mutations Using a Pharmacologic Approach. Blood (2015)

Atsushi NonamiMartin SattlerEllen WeisbergQingsong LiuJianming ZhangMatthew P. PatricelliAmanda L. ChristieAmy M. SaurNancy E. KohlAndrew L. KungHojong YoonTaebo SimNathanael S. GrayJames D. Griffin

Asymmetric Synthesis of (+)-Lentiginosine Using a Chiral Aziridine Based Approach. Tetrahedron Asymmetry (2014)

Cheminform Abstract: Asymmetric Synthesis of (+)‐Lentiginosine Using a Chiral Aziridine Based Approach.. ChemInform (2014)

Cheminform Abstract: Stereoselective Synthesis of (+)‐Polyoxamic Acid Starting With a Chiral Aziridine.. ChemInform (2014)

1
2
10 / page